Zenith Drugs Limited (NSE:ZENITHDRUG)
India flag India · Delayed Price · Currency is INR
42.65
-1.35 (-3.07%)
Aug 21, 2026, 3:29 PM IST

Zenith Drugs Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,7121,7121,3331,3161,145916.55
Revenue Growth
19.03%28.43%1.29%14.93%24.95%24.87%
Gross Profit
486.66486.66456.78459.6362.02189.44
Operating Income
61.1361.13112.13167.358655.05
Net Income
39.4339.4371.6195.3748.8131.38
Earnings Per Share
2.302.304.185.564.072.62
EPS Growth
4.56%-44.92%-24.90%36.70%55.53%3.60%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2.612.612.6387.432.7930.01
Total Debt
551.05551.05485.68239.33261.12188.09
Net Cash (Debt)
-548.44-548.44-483.05-151.9-258.33-158.08
Net Cash Growth
------
Net Cash Per Share
-31.99-31.99-28.17-8.86-21.53-13.17

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
88.6988.69-54.66-158.4-47.7251.53
Capital Expenditures
-97.09-97.09-321.13-53.3-55.71-52.42
Free Cash Flow
-8.41-8.41-375.79-211.7-103.43-0.89
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
28.42%28.42%34.26%34.92%31.61%20.67%
Operating Margin
3.57%3.57%8.41%12.71%7.51%6.01%
Pretax Margin
3.15%3.15%6.95%10.10%5.81%4.81%
Profit Margin
2.30%2.30%5.37%7.25%4.26%3.42%
FCF Margin
-0.49%-0.49%-28.19%-16.08%-9.03%-0.10%

Dividends

Fiscal YearFY 2024
Period EndingMar '24
Dividend Per Share
0.500
Dividend Per Share Growth
-
Dividend Yield
0.80%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
18.5415.3117.1711.27--
PS Ratio
0.430.350.920.82--